Abstract
Purpose of Review
The objectives of this article are to review the major changes in the staging of head and neck cancers and the rationale for the modifications.
Recent Findings
Information gathered from various institutional reports lead to a better understanding of the clinical and biological behavior of head and neck tumors, resulting in distinct outcomes, which were used to update the staging system.
Summary
This article reviews the changes in the staging of head and neck cancers published in the 8th edition of the AJCC/UICC TNM staging system.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Denoix PF. Note on the possible role of the International Union against Cancer in nomenclature, classification, analytical index, bibliography and documentation. Acta Unio Int Contra Cancrum. 1952;8(Special No):92–6.
(UICC), T.U.f.I.C.C. TNM History, Evolution and Milestones. 2017; Available from: https://www.uicc.org/sites/main/files/atoms/files/TNM_History_updated_June2017.pdf.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. editors. AJCC Cancer Staging Manual. 8th ed. New York: Springer International Publishing: American Joint Commission on Cancer; 2017.
• Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers–major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37. This article describes the most significant modifications of the staging system.
• International Consortium for Outcome Research (ICOR) in Head and Neck Cancer), Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, et al. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1138–48. This retrospective study included a large cohort of oral cancer patients from multiple centers in the world and identified optimal cutpoints for depth of invasion. The models that were evaluated in this study were used to define the changes in the T category of the AJCC 8 th edition.
• Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gonen M, et al. Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head Neck. 2016;38 Suppl 1:E1192-E1199. This study evaluated the microscopic extent of extranodal extension and its prognostic implications for oral cancer.
Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol. 2012;22(2):128–42.
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301.
• O'Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440–51. This study included a large number of patients from multiple centers to create a better staging system for patients with HPV-related oropharyngeal cancer.
Skulsky SL, O'Sullivan B, McArdle O, Leader M, Roche M, Conlon PJ, et al. Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN Clinical Practice Guidelines In Oncology. Head Neck. 2017;39(3):578–94.
• Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, et al. An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer. Thyroid. 2016;26(3):373–80. This international retrospective study showed that changing the cutpoint age from 45 to 55 years could prevent overstaging patients with low-risk disease and better estimate prognosis.
Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on cancer/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why? Thyroid. 2017;27(6):751–6.
Chen F, Lin L, Liu F, Yan L, Qiu Y, Wang J, et al. Three prognostic indexes as predictors of response to adjuvant chemoradiotherapy in patients with oral squamous cell carcinoma after radical surgery: a large-scale prospective study. Head Neck. 2019;41(2):301-308.
Bobdey S, Mair M, Nair S, Nair D, Balasubramaniam G, Chaturvedi P. A nomogram based prognostic score that is superior to conventional TNM staging in predicting outcome of surgically treated T4 buccal mucosa cancer: time to think beyond TNM. Oral Oncol. 2018;81:10–5.
Hay A, Migliacci J, Zanoni DK, Patel S, Yu C, Kattan MW, et al. Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands. Head Neck. 2018;40(5):1008–15.
Montero PH, Yu C, Palmer FL, Patel PD, Ganly I, Shah JP, et al. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer. 2014;120(2):214–21.
Pan JJ, Ng WT, Zong JF, Lee SWM, Choi HCW, Chan LLK, et al. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016;122(21):3307–15.
Ge MH, Cao J, Wang JY, Huang YQ, Lan XB, Yu B, et al. Nomograms predicting disease-specific regional recurrence and distant recurrence of papillary thyroid carcinoma following partial or total thyroidectomy. Medicine (Baltimore). 2017;96(30):e7575.
Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, et al. Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer. J Clin Oncol. 2017;35(36):4057–65.
Funding
This work was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Daniella Karassawa Zanoni, Snehal G. Patel, and Jatin P. Shah declare they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Head and Neck Cancers
Rights and permissions
About this article
Cite this article
Zanoni, D.K., Patel, S.G. & Shah, J.P. Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications. Curr Oncol Rep 21, 52 (2019). https://doi.org/10.1007/s11912-019-0799-x
Published:
DOI: https://doi.org/10.1007/s11912-019-0799-x